Parents’ Experiences of Childhood Cancer During the COVID-19 Pandemic: An Australian PerspectiveArticle Published on 2022-02-142023-07-07 Journal: Journal of pediatric psychology [Category] COVID19(2023년), [키워드] Australia Cancer childhood COVID-19 neutropenia pediatric Qualitative [DOI] 10.1093/jpepsy/jsab125 PMC 바로가기
SARS-CoV-2 anti-spike antibodies after vaccination in pediatric heart transplantation: A first report소아 심장 이식에서 백신 접종 후 SARS-CoV-2 안티 스파이크 항체: 첫 번째 보고Article Published on 2022-02-012022-09-11 Journal: The Journal of heart and lung transplantation : th [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] absence anti-spike antibody anti-spike IgG antibodies antibody Antibody Response Antibody testing children Complete detectable diabetes Diabetes Mellitus IgG IgG antibody median median age myocarditis neutropenia Patient paucity of data pediatric pediatric heart transplant. Pediatric patient Post-vaccine pre-vaccination proportion recipient rituximab SARS-CoV-2 SARS-CoV-2 anti-spike IgG SARS-CoV-2 vaccination SARS-CoV-2 viral infection solid organ solid organ transplant Support the antibody response the SARS-CoV-2 vaccination Viral viral infection was performed [DOI] 10.1016/j.healun.2021.11.001 PMC 바로가기 [Article Type] Article
Staphylococcus lugdunensis Urinary Tract Infection With Associated Neutropenic Feverarticle Published on 2022-01-192024-09-02 Journal: Cureus [Category] 대상포진, [키워드] Chemotherapy neutropenia neutropenic fever staphylococcus lugdunensis thrombocytopenia urinary tract infection [DOI] 10.7759/cureus.21432 PMC 바로가기 [Article Type] article
Impact of chemotherapy and immunotherapy on the composition and function of immune cells in COVID-19 convalescent with gynecological tumors부인과 종양과 코비드 -19 회복기에서 면역 세포의 조성 및 기능에 대한 화학 요법 및 면역 요법의 영향Research Paper Published on 2021-12-152022-09-01 Journal: Aging (Albany NY) [Category] SARS, 진단, [키워드] acute infection anti-viral activity B cells cancers caused Chemotherapy clonal expansion convalescent Convalescent patients coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 patient COVID-19 patients CoVs effort ENhance facilitated functional phenotype healthy donor ICIs Immune cell immunological change Immunological memory Immunotherapy Impact molecular feature molecular features neutropenia NK cells pandemic Patient patients PBMC PBMCs performed Peripheral blood peripheral blood samples proportion PROTECT Reinfection resurgence SARS-CoV-2 virus single cell sequencing Single-cell RNA sequencing T and B cells T cell T cells Treatment Tumor tumors [DOI] 10.18632/aging.203739 PMC 바로가기 [Article Type] Research Paper
Pediatric COVID-19: Low Incidence, but Possible Fatality—A Case Report and a Review of the LiteratureCase Report Published on 2021-12-032022-10-31 Journal: Children [Category] COVID-19, [키워드] Admission Adults Anemia antibiotic Anticoagulant antipyretics Antiviral bradycardia C-reactive protein children Clinical course Coagulopathy Complication consolidation Corticosteroids COVID-19 COVID-19 complication death Desaturation described died ferritin Health Hospitalization hydronephrosis incidence increased risk initiated International Intubated knowledge laboratory parameter Laboratory test lack literature lower lobe lung male management mechanically ventilated Microvascular thrombosis Mild Monocytes neutropenia normalized oropharyngeal swab parents Patient Pediatric patients Pneumonia polymerase chain positive Prothrombin time report resulting review RT-PCR SARS-CoV-2 Seizure Seizures Symptoms tested therapy Thoracic ureterovesical venous was performed [DOI] 10.3390/children8121128 PMC 바로가기 [Article Type] Case Report
SARS-CoV-2 in children with cancer or after haematopoietic stem cell transplant: An analysis of 131 patientsObservational Study Published on 2021-12-012022-10-05 Journal: European journal of cancer (Oxford, England : 1990 [Category] 임상, 치료기술, [키워드] 95% CI 95% confidence interval Analysis Asymptomatic baseline Cancer Care Cell Chemotherapy Child children clinical variable Comorbidity cough country COVID-19 COVID-19 symptoms Critical detectable determine died disease disease severity Factor FIVE full recovery haematopoietic stem cell transplantation help hospitalised HSCT identify immunodeficiency Infection intensive care management median median age Mild moderate neutropenia Odds ratio organ support outcome Patient patients patients with COVID-19 polymerase chain required risk SARS-CoV-2 severe COVID-19 severe disease severity significantly solid tumour Symptoms virus was used [DOI] 10.1016/j.ejca.2021.09.027 PMC 바로가기 [Article Type] Observational Study
Clonal Hematopoiesis of Indeterminate Potential Is Associated with Increased Age-Independent Morbidity and Mortality in Patients with COVID-19- the Beyond DNA COVID-19 ProjectConference abstract Published on 2021-11-242022-10-05 Journal: Blood [Category] 변종, [키워드] accounted affected age age and sex allele approved assays association ASXL1 ATAC-seq baseline Blood blueprint carried ChIP clinically collected common Comorbidities comparable Coverage COVID-19 COVID-19 diagnosis COVID-19 disease severity COVID-19 patient CRP CRS cytokine cytokine levels Cytokine release syndrome Cytokines database death defined described Detection limit DNA download elevated ELISA assay entire cohort figure Fisher Follow-up funding Genes grade 3 group had more hazard healthy individual Hematopoiesis Hospitalization hypoxemic hypoxic respiratory failure identify IL6 Increased increased mortality indeterminate indicated individuals Infection Inflammation Inflammatory inflammatory cascade Inflammatory marker IRB male Mayo Clinic MCP-1 median median age mononuclear cell morbidity Mortality MPL Mutation mutations neutropenia no difference observé Older pathophysiology Patient patients patients with COVID-19 PBMC Peripheral blood Potential proteomic study reached regression models remained Research resolved Respiratory failure RNA scale Sequencing severe disease severity Sex SF3B1 Single Cell ssDNA subsequent survival survival analysis TET2 the Kaplan-Meier method the WHO TNF-a TP53 two groups variables variant was performed WHO Wilcoxon rank sum with COVID-19 [DOI] 10.1182/blood-2021-151548 [Article Type] Conference abstract
Gilteritinib for Relapsed Acute Myeloid Leukaemia with FLT3 Mutation during the COVID-19 Pandemic: Real World Experience from the UK National Health ServiceConference abstract Published on 2021-11-232022-10-05 Journal: Blood [Category] 변종, [키워드] 95%CI Administered Allogeneic AML approved ASXL1 board Cell Chemotherapy clinically clinician collected Complete COVID-19 COVID-19 pandemic criteria curative database de novo disease domain dose download duplication education effective ELN European experience figure FLT3 Follow-up funding Gilteritinib haematological disorder healthcare hospital Hospital admission IDH1 IDH2 immunosuppressive infected with SARS-CoV-2 information inhibitor Intensive Jazz less majority male median median age Morphological Mortality Most patient mutated Mutation mutations myeloid National Health Service network neutropenia NHS nosocomial not differ NPM1 outcome pandemic Patient patients performance status Physicians proceed reached reducing Registered reported resource resources response Result risk RUNX1 Sequencing significantly speaker Support survival Takeda the median therapy Toxicity TP53 Transmission Treatment tyrosine United Kingdom [DOI] 10.1182/blood-2021-150169 [Article Type] Conference abstract
Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trial Research Published on 2021-11-042022-10-05 Journal: Nature Medicine [Category] 유전자 메커니즘, 임상, [키워드] 95% confidence interval ABC adverse event Breast cancer dalpiciclib Disease progression double-blind effective Endocrine incidence inhibitor leukopenia neutropenia pathway Patient phase 3 trial Placebo primary end point Randomized reached receive Serious Adverse Event shown significantly Support survival therapy Treatment [DOI] 10.1038/s41591-021-01562-9 [Article Type] Research
Decreased mortality and increased side effects in COVID-19 patients treated with IL-6 receptor antagonists: systematic review and meta-analysisIL-6 수용체 길항제로 치료받은 COVID-19 환자의 사망률 감소 및 부작용 증가 : 체계적인 검토 및 메타 분석Meta-Analysis Published on 2021-11-022022-09-01 Journal: Scientific Reports [Category] MERS, SARS, 임상, 진단, 치료법, [키워드] 1.26 antagonist antagonists baseline Cochrane Library COVID-19 COVID-19 patient COVID-19 patients database Decreased effective Epidemiology ICU IL-6 IL-6 receptor Immunotherapy impaired liver function Infectious diseases lower mortality mechanical ventilation Meta-analysis Mortality mortality risk neutropenia Patient patients hospitalized patients treated PMC PubMed Central random effect RCT receptor reducing mortality Research retrieved risk risk difference risk ratio Secondary infection secondary infections Side effect Side effects systematic review treated treating COVID-19 patients unique viral infection WHO [DOI] 10.1038/s41598-021-00726-4 PMC 바로가기 [Article Type] Meta-Analysis